Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage

OBJECTIVE: To evaluate the impact of methotrexate (MTX) dosage on clinical, functional and quality of life outcomes in patients with rheumatoid arthritis (RA) from two previous etanercept (ETN) trials after 24 months of treatment. METHODS: Patients with active RA in the ETN+MTX combination treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, G, Brock, F, Kerkmann, U, Kola, B, Huizinga, T W J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860865/
https://www.ncbi.nlm.nih.gov/pubmed/27175292
http://dx.doi.org/10.1136/rmdopen-2015-000186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860865/
https://www.ncbi.nlm.nih.gov/pubmed/27175292
http://dx.doi.org/10.1136/rmdopen-2015-000186

Ejemplares similares